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Abstract  
Introduction: Recently, the use of metal and plastic containers instead of clay containers in producing this 
type of cheese has provided the anaerobic condition for growing the bacterium and producing the botulinum 
toxin. In this case report was to introduce "clay cheese dug in the ground" as a source of botulinum toxin 
for the first time. 
Case Report: A 34-year-old man with dizziness, asthma, and inability to swallow for four days referred to the 
hospital emergency department. He had diplopia and ptosis for two days. During admission to the 
emergency, the patient was conscious without fever, but with dysarthria and bilateral ptosis, an impaired gag 
reflex, slow right papillary reaction to light, a decreased eye movement, and a decreased power of facial 
muscles and limbs. The patient reported the use of clay cheese in a week before referring to the emergency. 
Hematological, biochemical, electrocardiogram, magnetic resonance imaging, and chest X-ray assays were 
normal. According to the Centers for Disease Control and Prevention classification, these symptoms were 
related to botulism. The evaluation of serum samples, emission, and gastric juice confirmed botulism by type 
A toxin.  
Conclusion: Considering the clinical results of this case study, clay cheese, which is produced in the west of 
Iran, can be introduced as a new source of the botulinum toxin. 
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INTRODUCTION
Botulism is a disease caused by a neurotoxin 
called Botulinum Toxin (BT) produced by the 
anaerobic bacterium named Clostridium 
botulinum. Although it has a low prevalence, it is a 
dangerous disease with debilitating outcomes. 
When BT enters the body, it controls the release of 
Acetylcholine and avoids the neurotransmitter 
availability to muscles, leading to the muscle 
paralysis (1). The Center for Disease Control and 
Prevention (CDC) has established a supervision 
system called The National Botulism Surveillance 
System in America since 1970. This center aims to 
gather records and follow all cases affected by BT. 
The center divides the BT into four types based on 
the way of entering the body. They consist of A) 
infant botulism in which the bacterium is spread 
in the digestive system and produces BT; B) food-
borne botulism in which the bacterium is spread 
and grown in food and produces BT; C) wound 
botulism in which the wound is infected by the 
bacterium, followed by bacterium spread and BT 
distributes in the body; and D) other botulism 
types with unknown cause of poisoning, such as 
overdose while using BT for medical purposes. 
Adult intestinal toxemia as a rare case happens 
when BT enters the body in a way similar to infant 
botulism (2, 3). The CDC has reported 39 (20%) 
cases of food-borne botulism with 4% of death 
during 2015 (3). As the most common source of 
botulism is the use of canned food (because of its 
acidic property) (4), the aim of this case report 
was to introduce "clay cheese dug in the ground" 
as a source of botulinum toxin for the first time.  
CASE PRESENTATION 
A 34-year-old man with dizziness, dyspnea, and 
inability to swallow referred to the hospital 
emergency department. The patient presented 
with dizziness, followed by dyspnea, a gradual 
feeling of dryness in the throat, an impaired reflex, 
slow papillary reaction to light, a decreased eye 
movement, a decreased power of facial muscles 
and limbs, normal deep tendon reflexes (DTR), 
lack of focal neurologic signs, and respiratory 
failure. The patient reported the use of clay cheese 
in the week before referring to the emergency. In 
the laboratory evaluation, hematological and 
biochemical tests such as complete blood cell 
counts, and also serum level of sodium, potassium, 
blood sugar, BUN, and creatinine were normal. 
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electrocardiogram, magnetic resonance imaging, 
and chest X-ray were also reported as normal. The 
patient was under supportive therapy, respiratory 
care, cardiac monitoring, and pulse oximetry after 
transferring to the intensive care unit (ICU).  
Based on the clinical suspicion to botulism, 
diagnostic evaluations, including the evaluation of 
serum samples, emission, and gastric juice, were 
done to confirm the BT. The patient's history 
showed the use of cabbage salad, vegetables, and 
clay cheese in the last week. Thus samples of these 
foods were evaluated regarding the BT. The 
patient was treated with three doses of antitoxin. 
Neurology consultation was done a day after 
hospitalization. After three days, the patient was 
transferred to the infectious diseases ward. After 
11 days and resolving of ptosis, the power of 
organs reached the normal state (5/5), and the 
gag reflex was decreased; consequently, he was 
discharged with medication orders. Four days 
later, the BT test in blood and cheese samples 
came positive (toxin B) while it was negative in 
other food samples. 
The patients' wife also referred to the hospital 
with asthma and a feeling of dryness in the throat, 
followed by the inability to swallow, feeling of 
vomiting, and trouble speaking for four days. 
During admission to the emergency, the patient 
was conscious without a fever but, with dysarthria 
and bilateral ptosis, an impaired gag reflex, slow 
right papillary reaction to light, a decreased eye 
movement, a decreased power of facial muscles 
and limbs, normal DTR, and lack of focal 
neurologic signs and respiratory failure. This 
patient underwent supportive therapy and 
antitoxin prescription. In addition to these two 
patients, seven other members of the family 
referred to the hospital with the same signs of 
botulism to be treated. 
DISCUSSIONS 
Clostridium botulinum is an anaerobic 
microorganism and spore-forming bacillus that is 
found in the soil. It includes three types A, B, and 
C. This bacterium produces seven types of toxin A, 
B, C, D, E, F, and G with similar pharmacological 
but different serological properties. Human 
botulinum is caused by type C that produces four 
toxins A, B, E, and F (5-8). Clay cheese is 
introduced in this report as a source of BT for the 
first time. Clay cheese is a kind of traditional 
cheese produced in the Northwest of Iran. In the 
past, fresh cheese was collected in clay dishes and 
kept closed for six months under the ground. 
Nowadays, this type of cheese is produced in 
plastic or metal containers that provide the 
anaerobic condition for growing the bacterium 
and producing the toxin (7). 
Clinical signs of food-borne botulism include a 
range of neurologic signs of insensible weakness 
in motor or cranial nerves to severe respiratory 
failure or respiratory arrest; all of them are caused 
by the blockade of the neuromuscular junction in 
autonomic nerves (8, 9). Clinical signs are the 
same in all types of BT, but the severity and 
lethality are more in type A than in others (9). 
Thus this type is more important clinically. In the 
present case report, the recognized toxin was type 
A. Although food-borne botulism does not 
necessarily have digestive signs, constipation is 
the most common symptom. Furthermore, 
abdominal cramps, diarrhea, and vomiting may 
also be observed. The first neurologic signs are 
dry mouth, blurred vision, and double vision, 
followed by dysarthria, dysphonia, and dysphagia. 
The first digestive and neurologic signs occur 
within six hours to eight days (10). In the present 
case study, the above-mentioned sings happened 
at the same duration. Digestive and neurologic 
signs included dysarthria and bilateral ptosis, an 
impaired gag reflex, slow right papillary reaction 
to light, a decreased eye movement, and a 
decreased power of facial muscles and limbs. The 
clinical recovery takes from several weeks to 
several months because of a synopsis recovery in 
neuromuscular junction following supportive 
treatment such as mechanical ventilation (11, 12). 
In this case report, the patient was discharged 11 
days after the supportive treatment and recovered 
from clinical signs, which is consistent with the 
above-mentioned remarks. 
Nowadays, metal and plastic containers are used 
to produce clay cheese that provides an anaerobic 
condition for toxin production. Thus producing 
clay cheese in this way is dangerous, which 
necessitates the required training for people 
involved with the production of this kind of 
cheese. 
CONCLUSIONS 
Considering the clinical results of this case study, 
clay cheese, which is produced in the west of Iran, 
can be introduced as a new source of the 
botulinum toxin. This phenomenon can be due to 
changing the method of producing this type of 
cheese. 
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